SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Biocytogen inks non-exclusive VHH antibody licensing deal with Qilu Pharma

Biocytogen Pharmaceuticals (Beijing) entered a non-exclusive licensing agreement with Qilu Pharmaceutical covering a fully human VHH antibody molecule.

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.

Related stories